-
Je něco špatně v tomto záznamu ?
Nanofiber micro-dispersed oxidized cellulose as a carrier for topical antimicrobials: first experience
P. Lochman, M. Plodr, J. Páral, K. Smejkal
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20163259
DOI
10.1089/sur.2008.093
Knihovny.cz E-zdroje
- MeSH
- antiinfekční látky lokální terapeutické užití MeSH
- aplikace lokální MeSH
- bakteriální infekce farmakoterapie MeSH
- celulosa oxidovaná aplikace a dávkování MeSH
- Escherichia coli účinky léků izolace a purifikace MeSH
- gentamiciny terapeutické užití MeSH
- hojení ran MeSH
- infekce v ráně farmakoterapie MeSH
- modely nemocí na zvířatech MeSH
- nanovlákna aplikace a dávkování MeSH
- nosiče léků aplikace a dávkování MeSH
- prasata MeSH
- Pseudomonas aeruginosa účinky léků izolace a purifikace MeSH
- Staphylococcus aureus účinky léků izolace a purifikace MeSH
- výsledek terapie MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Micro-dispersed oxidized cellulose, already used for hemostasis, might be helpful for introduction of an antimicrobial drug. AIM: To examine the effect of topically applied gentamicin attached to a new biodegradable carrier formed by micro-dispersed oxidized cellulose in microfiber and nanofiber form for treatment of acute wound infection and to assess the influence of this carrier on healing. MATERIALS AND METHODS: A model of a full-thickness infected dermal wound was created in 12 female domestic pigs. The effectiveness of topical gentamicin delivered with micro-dispersed oxidized cellulose carrier was tested in acute wound infections caused by Staphylococcus aureus, Pseudomonas aeruginosa, or Escherichia coli. RESULTS: The effectiveness of nanofiber micro-dispersed oxidized cellulose with gentamicin was proved according to culture findings. When assessed macroscopically, 100% of wounds treated by the nanofiber product had no signs of local infection. When microfiber micro-dispersed oxidized cellulose was used, cultures demonstrated residual bacteria in 94.4% of treated incisions despite the absence of clinically recognized infection. CONCLUSIONS: Micro-dispersed oxidized cellulose carrier with a sufficient concentration of an attached antibiotic appears to be effective for the treatment of full-thickness skin infections. The positive influence of the product on the healing of a dermal incision was shown, and a good hemostatic effect was confirmed.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025178
- 003
- CZ-PrNML
- 005
- 20130124184525.0
- 007
- ta
- 008
- 120816s2010 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1089/sur.2008.093 $2 doi
- 035 __
- $a (PubMed)20163259
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Lochman, Petr $7 xx0092570 $u Department of Field Surgery, Faculty of Military Health Sciences, University of Defence, Trebesská St. 1575, Hradec Králové, Czech Republic. lochmpet@yahoo.com
- 245 10
- $a Nanofiber micro-dispersed oxidized cellulose as a carrier for topical antimicrobials: first experience / $c P. Lochman, M. Plodr, J. Páral, K. Smejkal
- 520 9_
- $a BACKGROUND: Micro-dispersed oxidized cellulose, already used for hemostasis, might be helpful for introduction of an antimicrobial drug. AIM: To examine the effect of topically applied gentamicin attached to a new biodegradable carrier formed by micro-dispersed oxidized cellulose in microfiber and nanofiber form for treatment of acute wound infection and to assess the influence of this carrier on healing. MATERIALS AND METHODS: A model of a full-thickness infected dermal wound was created in 12 female domestic pigs. The effectiveness of topical gentamicin delivered with micro-dispersed oxidized cellulose carrier was tested in acute wound infections caused by Staphylococcus aureus, Pseudomonas aeruginosa, or Escherichia coli. RESULTS: The effectiveness of nanofiber micro-dispersed oxidized cellulose with gentamicin was proved according to culture findings. When assessed macroscopically, 100% of wounds treated by the nanofiber product had no signs of local infection. When microfiber micro-dispersed oxidized cellulose was used, cultures demonstrated residual bacteria in 94.4% of treated incisions despite the absence of clinically recognized infection. CONCLUSIONS: Micro-dispersed oxidized cellulose carrier with a sufficient concentration of an attached antibiotic appears to be effective for the treatment of full-thickness skin infections. The positive influence of the product on the healing of a dermal incision was shown, and a good hemostatic effect was confirmed.
- 650 _2
- $a aplikace lokální $7 D000287
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiinfekční látky lokální $x terapeutické užití $7 D000891
- 650 _2
- $a bakteriální infekce $x farmakoterapie $7 D001424
- 650 _2
- $a celulosa oxidovaná $x aplikace a dávkování $7 D002483
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a nosiče léků $x aplikace a dávkování $7 D004337
- 650 _2
- $a Escherichia coli $x účinky léků $x izolace a purifikace $7 D004926
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a gentamiciny $x terapeutické užití $7 D005839
- 650 _2
- $a nanovlákna $x aplikace a dávkování $7 D057139
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $x izolace a purifikace $7 D011550
- 650 _2
- $a Staphylococcus aureus $x účinky léků $x izolace a purifikace $7 D013211
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a hojení ran $7 D014945
- 650 _2
- $a infekce v ráně $x farmakoterapie $7 D014946
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Plodr, Michal $7 xx0019420
- 700 1_
- $a Páral, Jiří, $d 1963- $7 mzk2008469111
- 700 1#
- $a Šmejkal, Karel. $7 xx0205391
- 773 0_
- $w MED00006469 $t Surgical infections $x 1557-8674 $g Roč. 11, č. 1 (2010), s. 29-32
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20163259 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130124184653 $b ABA008
- 999 __
- $a ok $b bmc $g 947220 $s 782524
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 11 $c 1 $d 29-32 $i 1557-8674 $m Surgical infections $n Surg Infect (Larchmt) $x MED00006469
- LZP __
- $a Pubmed-20120816/10/02